Quarterly report · Q1
4502.TEDINET S100RGTX
Period2023-04-01 → 2023-06-30
Filed2023-08-01
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.06T | 2023-04-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.03T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥972.5bn | 2022-04-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Operating income | ¥168.6bn | 2023-04-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥150.5bn | 2022-04-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥135.0bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥375.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥155.5bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥89.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥317.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥105.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥89.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥317.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥105.0bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Total assets | ¥14.79T | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥13.96T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥14.07T | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥7.87T | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥7.60T | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥6.92T | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.35T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥6.32T | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥5.68T | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥6.92T | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥6.35T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥316.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥533.5bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥646.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥849.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥92.4bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥977.2bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥84.2bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥266.5bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥607.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥94.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥57.8bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥709.1bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥215.7bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥57.51 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥204.29 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥67.94 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥57.12 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥201.94 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥67.56 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 46.8% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 45.5% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 44.9% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 625
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from sale of investments inv cf IFRS | CurrentYTDDuration | 543000000 | JPY |
| Proceeds from sales of business net of cash and cash equivalents divested inv cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from sales of business net of cash and cash equivalents divested inv cf IFRS | CurrentYTDDuration | 372000000 | JPY |
| Other inv cf IFRS | Prior1YTDDuration | -224000000 | JPY |
| Other inv cf IFRS | CurrentYTDDuration | -15000000 | JPY |
| Net cash provided by used in investing activities IFRS | Prior1YTDDuration | -94714000000 | JPY |
| Net cash provided by used in investing activities IFRS | CurrentYTDDuration | -266530000000 | JPY |
| Net increase decrease in short term borrowings and commercial paper fin cf IFRS | Prior1YTDDuration | － | JPY |
| Net increase decrease in short term borrowings and commercial paper fin cf IFRS | CurrentYTDDuration | 110000000000 | JPY |
| Proceeds from issuance of bonds and long term borrowings fin cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of bonds and long term borrowings fin cf IFRS | CurrentYTDDuration | 100000000000 | JPY |
| Redemption of bonds and repayments of long term borrowings fin cf IFRS | Prior1YTDDuration | -26804000000 | JPY |
| Redemption of bonds and repayments of long term borrowings fin cf IFRS | CurrentYTDDuration | -100088000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | Prior1YTDDuration | -26929000000 | JPY |
| Payments for purchase of treasury shares fin cf IFRS | CurrentYTDDuration | -2326000000 | JPY |
| Interest paid fin cf IFRS | Prior1YTDDuration | -22770000000 | JPY |
| Interest paid fin cf IFRS | CurrentYTDDuration | -19815000000 | JPY |
| Dividends paid fin cf IFRS | Prior1YTDDuration | -128873000000 | JPY |
| Dividends paid fin cf IFRS | CurrentYTDDuration | -130746000000 | JPY |
| Repayments of lease obligations fin cf IFRS | Prior1YTDDuration | -10325000000 | JPY |
| Repayments of lease obligations fin cf IFRS | CurrentYTDDuration | -10546000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | -17000000 | JPY |
| Other fin cf IFRS | CurrentYTDDuration | -4257000000 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | -215717000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | -57778000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | Prior1YTDDuration | -226190000000 | JPY |
| Net increase decrease in cash and cash equivalents before effect of exchange rate changes IFRS | CurrentYTDDuration | -231908000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 849695000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 533530000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 22485000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | 14759000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 645991000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 316380000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-08-01 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第147期第１四半期(自 2023年４月１日 至 2023年６月30日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)武田薬品工業株式会社 | |
| Company name in english cover page | FilingDateInstant | Takeda Pharmaceutical Company Limited | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長CEO クリストフ ウェバー | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪府大阪市中央区道修町四丁目１番１号（上記は登記上の本店所在地で実際の業務は「最寄りの連絡場所」で行っております。） | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当なし | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)該当なし | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区日本橋本町二丁目１番１号(武田薬品工業株式会社武田グローバル本社) | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京(3278)2111(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)グローバルファイナンス チーフアカウンティングオフィサー＆コーポレートコントローラー 竹田 徳正 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E00919 | |
| Fund code | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |